ISSN: 0094-6176

Journal Home

Journal Guideline

Seminars in Thrombosis and Hemostasis Q2 Unclaimed

Thieme Medical Publishers, Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Seminars in Thrombosis and Hemostasis is a journal indexed in SJR in Hematology and Cardiology and Cardiovascular Medicine with an H index of 112. It has an SJR impact factor of 0,801 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,801.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Cardiology and Cardiovascular Medicine (Q2) Hematology (Q2)

Price

- €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

0,801

SJR Impact factor

112

H Index

128

Total Docs (Last Year)

330

Total Docs (3 years)

7330

Total Refs

1120

Total Cites (3 years)

255

Citable Docs (3 years)

2.97

Cites/Doc (2 years)

57.27

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Cytokine: X Q2
Cytokine Q2
Hematological Oncology Q2
Platelets Q2
Stem Cells and Development Q2

Compare this journals

Aims and Scope

Best articles by citations

Factor Xa Is a Superior Target to Factor IIa for Antithrombotic Therapies

Venous Thromboembolism and Its Treatment in High-Risk Groups

A Reliable von Willebrand Factor: Ristocetin Cofactor Enzyme-Linked Immunosorbent Assay to Differentiate between Type 1 and Type 2 von Willebrand Disease

Anticoagulants in Thrombosis and Cancer: The Missing Link

Venous Thromboembolism in Medical Patients-The Scope of the Problem

Clinical Aspects of the Different Forms of Viral Hepatitis and Their Treatment

Virus Safety of Hemophilia Treatment in Germany and Austria-a Review of the Past 15 Years: A Eulogy for the 70th birthday of Professor Dr. rer. nat. Norbert Heimburger

Virus Safety of Hemophilia Treatment in Germany and Austria: A Tribute to Norbert Heimburger, Ph.D.

Virus Safety of Pasteurized Clotting Factor Concentrates

Development of Direct Thrombin Inhibitors in Comparison with Glycosaminoglycans

Low-Molecular-Weight Heparin or Oral Anticoagulation for Secondary Prevention of Deep Vein Thrombosis in Cancer Patients

Low-Molecular-Weight Heparins: Beyond Thrombosis in the Management of the Cancer Patient

SHOW MORE ARTICLES

Greetings from the German Hemophilia Society and from the Gesellschaft fur Thrombose- und Hämostaseforschung

von Willebrand Factor Collagen-Binding (Activity) Assay in the Diagnosis of von Willebrand Disease: A 15-Year Journey

Successful Treatment of Patients with von Willebrand Disease using a High-Purity Double-Virus Inactivated Factor VIII/von Willebrand Factor Concentrate (Immunate¬Æ)

Upper Extremity Deep Venous Thrombosis

MALDI Mass Spectrometry as a Tool for Characterizing Glycosaminoglycan Oligosaccharides and their Interaction with Proteins

Prevention of Venous Thromboembolism: Focus on Mechanical Prophylaxis

Reduction in Thrombus Extension and Clinical End Points in Patients after Initial Treatment for Deep Vein Thrombosis with the Fixed-Dose Body Weight-Independent Low Molecular Weight Heparin Certoparin

Alterations in Fibrin Structure in Patients with Liver Diseases

Antithrombin Attenuates Microvascular Leakage and Leukocyte-Endothelial Interaction in Response to Endotoxin

Sixteen Years of Treatment with Pasteurized Human Clotting Factor Concentrates in Children and Adolescents: A Pharmacosurveillance Investigation Comprising 727 Patient Years

Regulatory Role of Cytokines in Disseminated Intravascular Coagulation

Molecular Weight-Dependent Influence of Heparin on the Form of Tissue Factor Pathway Inhibitor Circulating in Plasma